Cell Innovation Partners, Japanese venture group, invests in Elastagen as part of a Second Close to the Series B Equity Financing.

Cell Innovation Partners, Japanese venture group, invests in Elastagen as part of a Second Close to the Series B Equity Financing. June 2016: Cell Innovation Partners Limited (hereinafter, “CIP”) has invested A$1 million in Elastagen Pty Ltd (hereinafter, “ELA”) (Headquarters: Sydney, Australia. CEO: Robert Daniels) through Cell Innovation Partners, L.P. ELA develops medical devices utilizing…

Details